Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients

NCT00311753 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

342

Enrollment

INDUSTRY

Sponsor class

Conditions

Embolism

Interventions

DRUG: Certoparin
DRUG: Heparin

Sponsor

Novartis Pharmaceuticals